For research purposes only. This compound is not FDA approved. All data presented is from clinical trials for educational reference.
Research Use Only
Peptides
$150+8% OFF$325+15% OFF
Tesamorelin 10mg
peptidetesamorelintesaghrhresearch
A 44-amino acid GHRH analog that stimulates pituitary gh secretion, studied for visceral adipose tissue reduction in clinical research. Premium Research Peptide.
Dosage
$69.9910MG
In Stock
5XEarn 349 points (5x points) with a free account
Add $80.01 more to save 8% off
Bundle & Save
Most Popular$225+12% OFF
Best Value$450+20% OFF
Discount applies automatically at checkout once your cart subtotal hits the tier.
Fast delivery
Free shipping
Overnight shipping available
We acceptVisaDiscoverAmexZelleCashApp
Product Details
Tesamorelin (Tesa)
Tesamorelin is a growth hormone-releasing hormone (GHRH) analogue. Each vial contains 10mg of lyophilized Tesamorelin for research purposes only. Third-party 7x tested with Certificate of Analysis (COA) available. Purity: >99%. COA Batch: MPTM001.
Description
Tesamorelin is a synthetic peptide analog of Growth Hormone-Releasing Hormone (GHRH) consisting of 44 amino acids. It is studied in vitro for its ability to stimulate endogenous growth hormone (GH) secretion and modulate metabolic and lipolytic pathways. This lyophilized formulation is designed for investigative use in controlled laboratory environments exploring endocrine signaling, cellular growth mechanisms, and metabolic regulation.
Specifications
- Unit Size: 10mg
- Form: Lyophilized powder
- Solubility: Soluble in sterile water or bacteriostatic water
- Storage: Store vial in a cool, dry place. After reconstitution, maintain solution between 2°C–8°C.
Application Context
Tesamorelin is utilized in scientific research to investigate:
- GH/IGF-1 axis activation
- Lipid metabolism and adipose tissue modulation
- Cellular regeneration and protein synthesis regulation
- Hypothalamic-pituitary signaling dynamics
Intended Use
This peptide is provided strictly for in vitro laboratory research use. It is not intended for human consumption or application of any kind, including therapeutic, cosmetic, or dietary uses.
Legal Disclaimer
This material has not been evaluated by the U.S. Food and Drug Administration (FDA). No product or content on this site is intended to diagnose, treat, cure, or prevent any disease. Use is limited to research institutions or qualified professionals operating within legal and ethical research frameworks.
Terms of Sale
All purchases from Midwest Peptide are final. By completing a transaction, the buyer certifies they are a qualified researcher or lab personnel with the appropriate expertise to safely handle research peptides. Responsibility for regulatory compliance, storage, and usage lies solely with the purchaser.
Frequently Asked Questions
What is tesamorelin?
+
Tesamorelin is a synthetic 44-amino-acid analog of human growth hormone-releasing hormone (GHRH), with N-terminal modifications that improve metabolic stability. In research it is studied for GHRH receptor signaling, somatotroph function, and IGF-1 axis dynamics. Supplied strictly for Research Use Only.
How is tesamorelin different from CJC-1295?
+
Both are GHRH analogs but use different parent sequences. Tesamorelin is based on full-length GHRH(1-44) with N-terminal modifications. CJC-1295 is based on the truncated GHRH(1-29) sequence. The two have distinct half-life, receptor-binding, and pharmacokinetic profiles in published research.
What is tesamorelin used for in research?
+
Tesamorelin is studied in preclinical research on GHRH receptor signaling, growth hormone pulsatility, IGF-1 axis dynamics, and visceral adipose tissue endpoints. All cited studies are conducted in rodent or in-vitro systems consistent with RUO classification.
What does the Certificate of Analysis verify?
Related Products
Other research peptides in this category
Learn More About Tesamorelin
Research articles and insights related to Tesamorelin
Tesamorelin Metabolic Syndrome Research: Multi-Endpoint Data
Tesamorelin metabolic syndrome research integrating visceral fat, glucose regulation, lipid profile, inflammatory markers, and hepatic steatosis endpoints. For research use only.
April 24, 2026
Tesamorelin Lean Mass Research: Muscle Preservation Studies
Tesamorelin lean mass research covering body composition preservation, muscle protein synthesis, muscle quality, and sarcopenia model research. For research use only.
April 24, 2026
Tesamorelin Lipodystrophy Research: Clinical Trial Literature in HIV Cohorts
Tesamorelin lipodystrophy clinical trial literature review covering HIV associated lipodystrophy studies, visceral adipose endpoints, and metabolic markers. For research use only.
April 14, 2026
Tesamorelin Lipolysis Research: Adipocyte Free Fatty Acid Studies
Tesamorelin lipolysis research covering adipocyte free fatty acid release, visceral depot specificity, and the growth hormone axis mediated mechanisms in rodent models. For research use only.
April 14, 2026
1 / 3
Important Research Notice
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.
